Carcinoma, Hepatocellular

Showing NaN - NaN of 22

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Carcinoma, Hepatocellular Trial in Worldwide (drug, biological, procedure)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Tucson, Arizona
  • +206 more
Jan 31, 2023

Carcinoma, Hepatocellular Trial in China, Korea, Republic of, Taiwan (Tepotinib 300 mg, Tepotinib 500 mg, Tepotinib 1000 mg)

Completed
  • Carcinoma, Hepatocellular
  • Tepotinib 300 mg
  • +4 more
  • Beijing, Beijing, China
  • +42 more
Aug 22, 2022

Carcinoma, Hepatocellular Trial in Worldwide (Atezolizumab, Bevacizumab, Sorafenib)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Phoenix, Arizona
  • +118 more
Jun 14, 2022

Carcinoma, Hepatocellular Trial in Taiwan (PI-88)

Completed
  • Carcinoma, Hepatocellular
  • Kaohsiung, Taiwan
  • +5 more
Jun 21, 2022

Carcinoma, Hepatocellular Trial in Worldwide (biological, drug, other)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • pembrolizumab
  • +2 more
  • Hefei, Anhui, China
  • +40 more
Mar 3, 2022

Carcinoma, Hepatocellular Trial in Worldwide (Refametinib (BAY86-9766), Sorafenib (BAY43-9006))

Completed
  • Carcinoma, Hepatocellular
  • Refametinib (BAY86-9766)
  • Sorafenib (BAY43-9006)
  • Louisville, Kentucky
  • +78 more
Apr 6, 2021

Carcinoma, Hepatocellular Trial in Worldwide (Refametinib (BAY86-9766))

Completed
  • Carcinoma, Hepatocellular
  • Refametinib (BAY86-9766)
  • Washington, District of Columbia
  • +57 more
Apr 6, 2021

Carcinoma, Hepatocellular Trial in Taiwan (Atezolizumab, Bevacizumab)

Recruiting
  • Carcinoma, Hepatocellular
  • Kaohsiung, Taiwan
  • +7 more
Mar 26, 2021

Carcinoma, Hepatocellular Trial in Worldwide (Placebo, GC33)

Completed
  • Carcinoma, Hepatocellular
  • Los Angeles, California
  • +56 more
Apr 1, 2020

Carcinoma, Hepatocellular Trial in China, Korea, Republic of, Taiwan (JNJ-42756493 (erdafitinib))

Completed
  • Carcinoma, Hepatocellular
  • JNJ-42756493 (erdafitinib)
  • Changchun, China
  • +9 more
Feb 17, 2020

Carcinoma, Hepatocellular Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Erlotinib (Tarceva), Placebo)

Completed
  • Carcinoma, Hepatocellular
  • Sorafenib (Nexavar, BAY43-9006)
  • +2 more
  • San Francisco, California
  • +126 more
May 16, 2019

Carcinoma, Hepatocellular Trial in Tainan, Taipei, Taoyuan City (Ramucirumab, FOLFOX4)

Completed
  • Carcinoma, Hepatocellular
  • Tainan, Taiwan
  • +2 more
May 3, 2018

Carcinoma, Hepatocellular Trial in Worldwide (Nexavar (Sorafenib, BAY43-9006), Placebo)

Completed
  • Carcinoma, Hepatocellular
  • Nexavar (Sorafenib, BAY43-9006)
  • Placebo
  • Birmingham, Alabama
  • +198 more
Jul 11, 2018

Carcinoma, Hepatocellular Trial in Hong Kong, Taiwan, Thailand (Foretinib)

Completed
  • Carcinoma, Hepatocellular
  • Hong Kong, Hong Kong
  • +6 more
Jul 14, 2017

Carcinoma, Hepatocellular Trial in China, Taiwan, Thailand (Capecitabine, Peginterferon alfa-2a)

Completed
  • Carcinoma, Hepatocellular
  • Beijing, China
  • +7 more
Nov 1, 2016

Carcinoma, Hepatocellular Trial in Worldwide (Onartuzumab, Sorafenib)

Completed
  • Carcinoma, Hepatocellular
  • Sarasota, Florida
  • +9 more
Nov 1, 2016

Carcinoma, Hepatocellular Trial in Tainan, Taipei, Taoyuan (Vandetanib, Best Supportive Care)

Completed
  • Carcinoma, Hepatocellular
  • Tainan, Taiwan
  • +2 more
Aug 29, 2016

Carcinoma, Hepatocellular Trial in Korea, Republic of, Taiwan (Sorafenib, BIBF 1120)

Completed
  • Carcinoma, Hepatocellular
  • Seoul, Korea, Republic of
  • +15 more
Feb 9, 2016

Carcinoma, Hepatocellular Trial in China, Korea, Republic of, Taiwan (Sorafenib (Nexavar, BAY43-9006), Placebo)

Completed
  • Carcinoma, Hepatocellular
  • Sorafenib (Nexavar, BAY43-9006)
  • Placebo
  • Hefei, Anhui, China
  • +22 more
Mar 26, 2014

Carcinoma, Hepatocellular Trial in Worldwide (BAY86-9766 MEK Inhibitor + Sorafenib)

Completed
  • Carcinoma, Hepatocellular
  • BAY86-9766 MEK Inhibitor + Sorafenib
  • Shatin, New Territories, Hong Kong
  • +14 more
Sep 5, 2013

Carcinoma, Hepatocellular Trial in Worldwide (sunitinib malate, sorafenib)

Terminated
  • Carcinoma, Hepatocellular
  • Fountain Valley, California
  • +170 more
Dec 7, 2012

Hepatocellular Carcinoma Non-resectable, Hepatocellular Carcinoma Recurrent, Carcinoma, Hepatocellular Trial in Worldwide

Terminated
  • Hepatocellular Carcinoma Non-resectable
  • +12 more
  • Beverly Hills, California
  • +162 more
Sep 7, 2012